Falling back into spec territory. What a joke. At the end of the day the Co is too blame.
Major holders would be supporting this if things were OK.
Starting to sound fishy to me. this is way oversold IMO.
Which if correct then more intelligent people than i should be buying in and they are not.
- Forums
- ASX - By Stock
- $2 party
Falling back into spec territory. What a joke. At the end of the...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
|
|||||
Last
$1.97 |
Change
-0.005(0.25%) |
Mkt cap ! $515.2M |
Open | High | Low | Value | Volume |
$1.95 | $2.00 | $1.89 | $1.350M | 696.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 86 | $1.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.98 | 14147 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 86 | 1.960 |
2 | 3500 | 1.950 |
1 | 2000 | 1.945 |
3 | 7800 | 1.940 |
1 | 2000 | 1.935 |
Price($) | Vol. | No. |
---|---|---|
1.980 | 14147 | 3 |
1.985 | 2000 | 1 |
1.990 | 2000 | 1 |
1.995 | 2759 | 2 |
2.000 | 6875 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online